AKT1 and liver cancer: Furthermore, mechanistic studies, a limitation of this study, may also investigate the mechanisms by which NAD inhibition mediates Erk and Akt signaling differently in liver cancer cell lines through proof of principle studies, such as gene silencing or knockdown models.